Naloxone saves lives by reversing overdose of heroin, fentanyl, or prescription opiate pain medications. Free naloxone is available to anyone who is at-risk of overdose, or who knows someone who is at risk of overdose.
The Erie County Health Department and the Regional Recovery Consortium have launched a new website at NarcanErieOhio.com where anyone in Ohio who is at-risk or knows someone who is at-risk of drug overdose can order free naloxone, also known as Narcan®. After completing a brief training and questionnaire, the naloxone is mailed to the address provided.
Erie County has suffered from 217 overdose deaths since 2007. Naloxone prevents death by restoring normal breathing to a person who is overdosing.
Naloxone is a medication which binds to opioid receptors and can reverse and block the effects of opioids. It can very quickly restore normal breathing to a person whose breathing has slowed or stopped as a result of overdosing with heroin, fentanyl, or prescription opioid pain medications.
Although traditionally administered by emergency response personnel, naloxone is a single dose nasal mist with no assembly required, and can be administered by minimally trained people. You may consider carrying naloxone if you, a friend, or family member have a prescription for opioid pain medication, misuse opioid pain medications, or have a history of using any type of illegal drugs.
To order free naloxone by mail, visit NarcanErieOhio.com to complete the brief training and questionnaire. Your free naloxone will be mailed to the address you provide within 3 business days. The naloxone will arrive in discrete packaging.
This work is funded in whole or in part by a grant awarded by the Ohio Department of Health, Office of Health Improvement and Wellness, Violence and Injury Prevention Section, and as a sub-award of a grant issued by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the State Opioid Response (SOR) grant, Federal Award Identification Number H79TI081684, and CFDA number 93.788, and as a sub-award of a grant issued by the Centers for Disease Control and Prevention under the Overdose Data to Action grant, CFDA number 93.136.